Drug intelligence / Profile preview

modified Changpu Yujin Tang

Development stage
Preclinical
Lead developer
Tianjin Huanhu Hospital
Modality
Small Molecules
Administration
Oral, Rectal
01

Overview

Modified Changpu Yujin Tang is a Traditional Chinese Medicine (TCM) herbal formulation developed and utilized by researchers at Tianjin Huanhu Hospital for the treatment of convulsive status epilepticus (CSE). The formula is a modification of the classic Changpu Yujin Tang, which traditionally contains *Acorus tatarinowii* (Shichangpu) and *Curcuma aromatica* (Yujin). In the context of CSE, the modification typically involves the addition of herbs such as *Arisaema cum Bile* (Dan Nan Xing) and *Bambusae Caulis in Taeniam* (Zhu Ru) to enhance its ability to clear heat, resolve phlegm, and open the orifices. Pharmacologically, the decoction is thought to exert anticonvulsant and neuroprotective effects by modulating neurotransmitter systems—specifically increasing GABAergic inhibition and reducing glutamatergic excitotoxicity—and by suppressing neuroinflammatory cytokines like IL-6 and TNF-alpha. It is generally administered as an adjunctive therapy alongside standard Western anti-epileptic drugs to improve consciousness recovery and reduce seizure recurrence.

Other names
Jiajian Changpu Yujin TangModified Acorus and Curcuma DecoctionModified Changpu Yujin Decoction
02

Targets

GABRA1 (Gamma-aminobutyric acid type A receptor alpha 1 subunit)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on modified Changpu Yujin Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on modified Changpu Yujin Tang.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call